Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations

Labetalol is a drug that exhibits both alpha and beta-adrenergic receptor-blocking properties. The American Heart Association/American Stroke Association (AHA/ASA) has recommended labetalol as an initial treatment option for the management of severe hypertension. The physiologically based pharmacoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafsa, Hafsa, Zamir, Ammara, Rasool, Muhammad Fawad, Imran, Imran, Saeed, Hamid, Ahmad, Tanveer, Alsanea, Sary, Alshamrani, Ali A., Alruwaili, Abdullah H., Alqahtani, Faleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696499/
https://www.ncbi.nlm.nih.gov/pubmed/36365181
http://dx.doi.org/10.3390/pharmaceutics14112362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696499/
https://www.ncbi.nlm.nih.gov/pubmed/36365181
http://dx.doi.org/10.3390/pharmaceutics14112362

Ejemplares similares